BMS-488043

• Description:

  BMS-488043 is a novel and unique oral small molecule HIV fusion inhibitor that inhibits the attachment of Human Immunodeficiency Virus type 1 (HIV-1) to CD4 (+) lymphocytes.BMS-488043 is used for the treatment of immune disorders, infections, and genitourinary disorders, and can be used in the study of HIV infect

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  422.43

• Molecular Formula:

  C22H22N4O5

• Notes:

  Research use only, not for human use.

• Receptor:

  HIV Protease

• CAS Number:

  452296-83-2